Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 168.83 USD 2.52% Market Closed
Market Cap: 24.8B USD

Wall Street
Price Targets

BIIB Price Targets Summary
Biogen Inc

Wall Street analysts forecast BIIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIIB is 179.46 USD with a low forecast of 119.18 USD and a high forecast of 273 USD.

Lowest
Price Target
119.18 USD
29% Downside
Average
Price Target
179.46 USD
6% Upside
Highest
Price Target
273 USD
62% Upside
Biogen Inc Competitors:
Price Targets
CRBU
Caribou Biosciences Inc
507% Upside
REGN
Regeneron Pharmaceuticals Inc
7% Upside
APLS
Apellis Pharmaceuticals Inc
84% Upside
ZEAL
Zealand Pharma A/S
53% Upside
XOMA
XOMA Corp
120% Upside
PEB
Pacific Edge Ltd
25% Downside
BIOPOR
Bioporto A/S
286% Upside
LVTX
LAVA Therapeutics NV
21% Downside

Revenue
Forecast

Revenue Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 3 years is -1%.

5%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 3 years is 4%.

2%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Biogen Inc

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 3 years is 14%.

2%
Past Growth
14%
Estimated Growth
Estimates Accuracy
19%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIIB's stock price target?
Price Target
179.46 USD

According to Wall Street analysts, the average 1-year price target for BIIB is 179.46 USD with a low forecast of 119.18 USD and a high forecast of 273 USD.

What is Biogen Inc's Revenue forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 3 years is -1%.

What is Biogen Inc's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 3 years is 4%.

What is Biogen Inc's Net Income forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 3 years is 14%.

Back to Top